These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10664245)

  • 21. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
    Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
    Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Separation and pharmaco-toxicological studies of the enantiomers of Ifosfamide].
    Blaschke G; Hilgard P; Maibaum J; Niemeyer U; Pohl J
    Arzneimittelforschung; 1986 Oct; 36(10):1493-5. PubMed ID: 3814210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
    Al-Saadi MS; Rostom SA; Faidallah HM
    Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
    Samanta S; Pain A; Dutta S; Sanyal U
    J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Strategies for studies on mechanism of action of antineoplastic agents].
    Kuśnierczyk H
    Postepy Hig Med Dosw; 1995; 49(1):85-96. PubMed ID: 8657622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases.
    Kruczynski A; Etiévant C; Perrin D; Imbert T; Colpaert F; Hill BT
    Br J Cancer; 2000 Dec; 83(11):1516-24. PubMed ID: 11076662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor in vitro evaluation of certain derivatives of pyrido-1,2-thiazines.
    Malinka W; Kaczmarz M; Redzicka A
    Acta Pol Pharm; 2004 Dec; 61 Suppl():100-2. PubMed ID: 15909956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro and in-vivo antitumour activity of physalins B and D from Physalis angulata.
    Magalhães HI; Veras ML; Torres MR; Alves AP; Pessoa OD; Silveira ER; Costa-Lotufo LV; de Moraes MO; Pessoa C
    J Pharm Pharmacol; 2006 Feb; 58(2):235-41. PubMed ID: 16451752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo pharmacological characterisation of the antitumour properties of pyrido[1',2':1,2]imidazo[4,5-h]quinazoline.
    Dupuy M; Blache Y; Bailly C; Poujol S; Chapat JP; Pinguet F
    Anticancer Res; 2002; 22(6A):3365-71. PubMed ID: 12530088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
    Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
    J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
    Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
    Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced antitumour activity of 15-residue bovine lactoferricin derivatives containing bulky aromatic amino acids and lipophilic N-terminal modifications.
    Eliassen LT; Haug BE; Berge G; Rekdal O
    J Pept Sci; 2003 Aug; 9(8):510-7. PubMed ID: 12952392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice.
    Cemazar M; Parkins CS; Holder AL; Kranjc S; Chaplin DJ; Sersa G
    Anticancer Res; 2001; 21(2A):1151-6. PubMed ID: 11396155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of anti-leukemia molecular mechanism of ITR-284, a carboxamide analog, in leukemia cells and its effects in WEHI-3 leukemia mice.
    Wen YF; Yang JS; Kuo SC; Hwang CS; Chung JG; Wu HC; Huang WW; Jhan JH; Lin CM; Chen HJ
    Biochem Pharmacol; 2010 Feb; 79(3):389-98. PubMed ID: 19765549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis.
    Cozzolino R; Palladino P; Rossi F; Calì G; Benedetti E; Laccetti P
    Carcinogenesis; 2005 Apr; 26(4):733-9. PubMed ID: 15661812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QSAR of acridines, III. Structure-activity relationship for antitumour imidazoacridinones and intercorrelations between in vivo and in vitro tests.
    Mazerska Z; Augustin E; Dziegielewski J; Chołody MW; Konopa J
    Anticancer Drug Des; 1996 Jan; 11(1):73-88. PubMed ID: 8639249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.